Mabpharm-B (02181) announced interim results: 截至二零二六年六月三十日止六個月之中期業績公告, net profit attributable to owners RMB31.4M Title: 截至二零二六年六月三十日止六個月之中期業績公告 Revenue: RMB4.0bn Net profit: RMB31.4M Profit attributable to owners: RMB31.4M
